Anthony S. Fauci, MD, director of the National Institute of Allergy and Infectious Diseases (NIAID) at the U.S. National Institutes of Health
Dr. Fauci oversees an extensive research portfolio focused on infectious and immune-mediated diseases. As the long-time chief of the NIAID Laboratory of Immunoregulation, he has made many seminal contributions in basic and clinical research and is one of the world’s most-cited biomedical scientists. He was one of the principal architects of the President’s Emergency Plan for AIDS Relief (PEPFAR), a program that has saved millions of lives throughout the developing world.
Jim Yong Kim, (@JimYongKim), MD, PhD, Vice Chairman and Partner at Global Infrastructure Partners, a fund that invests in infrastructure projects across several sectors around the world.
From July 2012 to February 2019, Kim served as the 12th President of the World Bank Group. Soon after he assumed that position, the organization established two goals to guide its work: to end extreme poverty by 2030; and to boost shared prosperity, focusing on the bottom 40 percent of the population in developing countries.
During Kim’s tenure, the World Bank Group supported the development priorities of countries at levels never seen outside of a financial crisis. Along with partners, the World Bank achieved two successive, record replenishments of the institution’s fund for the poorest countries. The World Bank Group also launched several innovative financial instruments, including facilities to address infrastructure needs, prevent pandemics, and help the millions of people forcibly displaced from their homes by climate shocks, conflict, and violence.
A physician and anthropologist, Kim’s career has revolved around health, education, and improving the lives of the poor. Before joining the World Bank Group, he served as the President of Dartmouth College and held professorships at Harvard Medical School and the Harvard School of Public Health. From 2003 to 2005, Kim served as Director of the World Health Organization’s HIV/AIDS department. He led WHO’s “3 by 5” initiative, the first-ever global goal for AIDS treatment, which greatly expanded access to antiretroviral medication in developing countries. In 1987, Kim co-founded Partners In Health, a non-profit medical organization that now works in poor communities on four continents.
Kim received a MacArthur “Genius” Fellowship, was recognized as one of America’s “25 Best Leaders” by U.S. News & World Report, and was named one of TIME magazine’s “100 Most Influential People in the World.”
George Q. Daley, MD, PhD, Dean of Harvard Medical School and the Caroline Shields Walker Professor of Medicine at HMS
Dean Daley is an internationally recognized leader in stem cell science and cancer biology. He is also a longtime member of the HMS faculty whose work spans the fields of basic science and clinical medicine.
Daley has been professor of biological chemistry and molecular pharmacology at HMS since 2010 and was an investigator of the Howard Hughes Medical Institute from 2008 until he resigned in 2017 upon assuming the Deanship. He previously held, as its inaugural incumbent, the Samuel E. Lux, IV Chair in Hematology/Oncology at Boston Children’s Hospital and was the Robert A. Stranahan Professor of Pediatrics and Professor of Biological Chemistry and Molecular Pharmacology at HMS.
A former chief resident in medicine at Massachusetts General Hospital (1994-95), Daley maintained an active clinical practice in hematology/oncology at Mass General and then at Boston Children’s, until assuming his administrative role as director of the Pediatric Stem Cell Transplantation Program at Dana-Farber/Boston Children's Cancer and Blood Disorders Center, a post he held until Jan. 2017.
He has served since 1995 as a member of the faculty of the Harvard-MIT Division of Health Sciences and Technology (HST), since 2004 as a founding member of the executive committee of the Harvard Stem Cell Institute, and since 2009 as an associate member of the Broad Institute of MIT and Harvard and as a core faculty member of the Manton Center for Orphan Disease Research at Boston Children’s.
Daley’s research focuses on the use of mouse and human disease models to identify mechanisms that underlie blood disorders and cancer. His lab aims to define fundamental principles of how stem cells contribute to tissue regeneration and repair and improve drug and transplantation therapies for patients with malignant and genetic bone marrow disease.
Beyond his research, Daley has been a principal figure in developing international guidelines for conducting stem cell research and for the clinical translation of stem cells, particularly through his work with the International Society for Stem Cell Research, for which he has served in several leadership positions, including president (2007-08). He has also testified before Congress and spoken in forums worldwide on the scientific and ethical dimensions of stem cell research and its promise in treating disease.
After earning his bachelor's degree magna cum laude from Harvard in 1982, Daley went on to earn his PhD in biology (1989) at MIT, working in David Baltimore’s laboratory at the MIT-affiliated Whitehead Institute for Biomedical Research.
He received his MD from HMS, graduating in 1991 with the rare distinction of summa cum laude. He then pursued clinical training in internal medicine at Mass General and was a clinical fellow at Brigham and Women’s and Boston Children’s hospitals. While running a laboratory as a Whitehead Fellow at the Whitehead Institute, he joined the HMS faculty as an assistant professor in 1995. He was promoted to associate professor in 2004, was named to an endowed chair at Boston Children’s in 2009 and became a full professor at HMS in 2010.
Daley's teaching efforts include serving as course director for the Molecular Medicine course at HMS and for an undergraduate course on stem cells in disease in the Harvard Faculty of Arts and Sciences. Earlier, for more than a decade, he led the Research in Health Sciences and Technology course in the HST program. He has trained dozens of graduate students and postdoctoral fellows and is a frequent participant in seminars and grand rounds at schools and hospitals in the Boston area and beyond. In 2012 he was recognized with the HMS A. Clifford Barger Excellence in Mentoring Award.
Important contributions from the Daley laboratory have included the creation of customized stem cells to treat genetic immune deficiency in a mouse model (together with Rudolf Jaenisch), the differentiation of germ cells from embryonic stem cells, the generation of disease-specific pluripotent stem cells by direct reprogramming of human fibroblasts, and demonstration of the role of the LIN28/let-7 pathway in cancer. In past research, he demonstrated the central role of the BCR/ABL oncoprotein in human chronic myelogenous leukemia, work that provided critical target validation for development of Gleevec, a highly successful chemotherapeutic agent.
Daley was an inaugural winner of the National Institutes of Health Director’s Pioneer Award for highly innovative research (2004). His numerous honors include the American Philosophical Society’s Judson Daland Prize for achievement in patient-oriented research, the American Pediatric Society’s E. Mead Johnson Award for contributions to stem cell research, the American Society of Hematology’s E. Donnall Thomas Prize for advances in human-induced pluripotent stem cells and the International Chronic Myeloid Leukemia Foundation’s Janet Rowley Prize for outstanding lifetime contributions to the understanding and/or treatment of the disease. He is an elected member of the National Academy of Medicine and the American Society for Clinical Investigation, among other professional societies.
Dr. Paul Farmer, MD, PhD, Kolokotrones University Professor of Global Health and Social Medicine, Chair of the Department of Global Health and Social Medicine; Chief, Division of Global Health Equity, Brigham and Women’s Hospital; Co-founder, Partners In Health
Medical anthropologist and physician Paul Farmer has dedicated his life to improving health care for the world's poorest people. Dr. Farmer holds an MD and PhD from Harvard University, where he is the Kolokotrones University Professor and the Chair of the Department of Global Health and Social Medicine at Harvard Medical School. He is co-founder and chief strategist of Partners In Health (PIH), an international non-profit organization that since 1987 has provided direct health care services and undertaken research and advocacy activities on behalf of those who are sick and living in poverty. He is professor of medicine and chief of the Division of Global Health Equity at Brigham and Women’s Hospital.
Dr. Farmer is the recipient of numerous honors, including the Bronislaw Malinowski Award and the Margaret Mead Award from the Society for Applied Anthropology, the Outstanding International Physician (Nathan Davis) Award from the American Medical Association, a John D. and Catherine T. MacArthur Foundation Fellowship, and, with his PIH colleagues, the Hilton Humanitarian Prize. He is a member of the Institute of Medicine of the National Academy of Sciences and of the American Academy of Arts and Sciences.
Date & Time
Monday, November 2, 2020 at 12:00pm EDT